Perspectives of future lung toxicology studies using human pluripotent stem cells
Authors:
Open Access
- 1 January 2022
- journal article
- review article
- Published by Springer Nature in Archives of Toxicology
- Vol. 96 (2) , 389-402
Abstract
The absence of in vitro platforms for human pulmonary toxicology studies is becoming an increasingly serious concern. The respiratory system has a dynamic mechanical structure that extends from the airways to the alveolar region. In addition, the epithelial, endothelial, stromal, and immune cells are highly organized in each region and interact with each other to function synergistically. These cells of varied lineage, particularly epithelial cells, have been difficult to use for long-term culture in vitro, thus limiting the development of useful experimental tools. This limitation has set a large distance between the bench and the bedside for analyzing the pathogenic mechanisms, the efficacy of candidate therapeutic agents, and the toxicity of compounds. Several researchers have proposed solutions to these problems by reporting on methods for generating human lung epithelial cells derived from pluripotent stem cells (PSCs). Moreover, the use of organoid culture, organ-on-a-chip, and material-based techniques have enabled the maintenance of functional PSC-derived lung epithelial cells as well as primary cells. The aforementioned technological advances have facilitated the in vitro recapitulation of genetic lung diseases and the detection of ameliorating or worsening effects of genetic and chemical interventions, thus indicating the future possibility of more sophisticated preclinical compound assessments in vitro. In this review, we will update the recent advances in lung cell culture methods, principally focusing on human PSC-derived lung epithelial organoid culture systems with the hope of their future application in toxicology studies.Keywords
Funding Information
- KYORIN Pharmaceutical Co., Ltd.
- Japan Agency for Medical Research and Development (JP17bm0804007, JP19bm0704037)
This publication has 133 references indexed in Scilit:
- Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADMEArchives of Toxicology, 2013
- Vertebrate Endoderm Development and Organ FormationAnnual Review of Cell and Developmental Biology, 2009
- Basal cells as stem cells of the mouse trachea and human airway epitheliumProceedings of the National Academy of Sciences, 2009
- Animal models of acute lung injuryAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Predicting drug‐induced changes in QT interval and arrhythmias: QT‐shortening drugs point to gaps in the ICHS7B GuidelinesBritish Journal of Pharmacology, 2008
- The branching programme of mouse lung developmentNature, 2008
- The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?The International Journal of Biochemistry & Cell Biology, 2008
- Thyroid Transcription Factor in Differentiating Type II CellsAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- Idiosyncratic drug hepatotoxicityNature Reviews Drug Discovery, 2005
- Drug-Induced Prolongation of the QT IntervalNew England Journal of Medicine, 2004